Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Microba Life Sciences Limited ( (AU:MAP) ).
Microba Life Sciences Limited, an entity listed on the ASX under the code MAP, announced the cessation of 400,000 securities due to the expiry of an option without exercise or conversion as of November 24, 2024. This cessation may impact the company’s issued capital structure and reflects a routine adjustment in its securities management.
More about Microba Life Sciences Limited
YTD Price Performance: 30.0%
Average Trading Volume: 344,285
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: A$116.4M
For an in-depth examination of MAP stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue